Rituxan
NDC 50242-053 · Genentech, Inc.
Generic namerituximab
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS
Active ingredient(s)RITUXIMAB
Strength10 mg/mL
Pharmacologic classCD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]
Marketing categoryBLA
Packages
50242-053-06 — 1 VIAL, SINGLE-USE in 1 CARTON (50242-053-06) / 50 mL in 1 VIAL, SINGLE-USE
Billed under HCPCS
J9312 — Injection, rituximab, 10 mg Medicare Part B payment limit (ASP + 6%): $73.28
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0069-0238 — rituximab-pvvr, 0069-0249 — rituximab-pvvr, 50242-051 — rituximab, 50242-108 — rituximab and hyaluronidase, 50242-109 — rituximab and hyaluronidase, 55513-224 — rituximab-arrx, 55513-326 — rituximab-arrx, 63459-103 — rituximab-abbs, 63459-104 — rituximab-abbs